You are here:
ciclesonide 80mcg , 160mcg inhaler (Alvesco)
Advice
Following an abbreviated submission
ciclesonide inhaler (Alvesco®) is accepted for use within NHS Scotland at high doses (up to 640mcg daily for up to 12 weeks) to control persistent asthma in adolescents and adults (12 years and older).
The higher dose should be used in patients for whom ciclesonide is an appropriate choice of maintenance inhaled corticosteroid therapy. Alternative inhaled steroids are available at lower costs.
Drug Details
| Drug Name: | ciclesonide 80mcg , 160mcg inhaler (Alvesco) |
|---|---|
| SMC Drug ID: | 412/07 |
| Manufacturer: | Altana Pharma Ltd |
| Indication: | Asthma in adolescents and adults (12 years and older) |
| BNF Category: | |
| Sub Category: | 3.3 Cromoglicate and related therapy and leukotriene receptor antagonists |
| Submission Type: | Abbreviated Submission |
| Status: | Accepted |
| Date Advice Published: | 12 November 2007 |